Profile picture

Doctor Paul M Haller

Medical University of Vienna, Vienna (Austria)
Membership: FESC Member EAPCI Member HFA Member
Follow
Biography
Dr. Paul Haller earned his MD from the Medical University of Vienna, a doctorate in medicine (Dr. med.) from the Faculty of Medicine at the University of Hamburg, and a PhD in Vascular Biology from the Medical University of Vienna. He has received clinical training in Internal Medicine and Cardiology at the University Heart and Vascular Center Hamburg, Germany, and Medical University of Vienna, Austria, and completed a post-doctoral research fellow in cardiovascular clinical trials at the TIMI Study Group, Brigham and Women's Hospital and Harvard Medical School.
Logo ESC

Contributor content

Heart failure risk assessment using biomarkers in patients with atrial fibrillation: analysis of 32,041 patients from the COMBINE-AF study
Presentation
Heart failure risk assessment using biomarkers in patients with atrial fibrillation: analysis of 32,041 patients from the COMBINE-AF study
Biomarker-based prediction of fatal and non-fatal cardiovascular outcomes in individuals of the general population with and without diabetes mellitus
Presentation
Biomarker-based prediction of fatal and non-fatal cardiovascular outcomes in individuals of the general population with and without diabetes mellitus
Characteristics and outcomes of patients with suspected acute myocardial infarction according to rising and falling patterns of high-sensitive cardiac troponin
Presentation
Characteristics and outcomes of patients with suspected acute myocardial infarction according to rising and falling patterns of high-sensitive cardiac troponin
The association of anemia with high-sensitive cardiac troponin and its influence on the ESC 0/1h and 0/3h algorithms to triage patients with suspected acute myocardial infarction
Presentation
The association of anemia with high-sensitive cardiac troponin and its influence on the ESC 0/1h and 0/3h algorithms to triage patients with suspected acute myocardial infarction
Performance of the ESC 0/1h- and 0/3h-algorithm for the early diagnosis of myocardial infarction in patients with diabetes mellitus
Presentation
Performance of the ESC 0/1h- and 0/3h-algorithm for the early diagnosis of myocardial infarction in patients with diabetes mellitus
Changes in extracellular vesicles during and after STEMI and potential influences of remote ischemic conditioning
Presentation
Changes in extracellular vesicles during and after STEMI and potential influences of remote ischemic conditioning
The expression of pro-coagulatory endothelial- and monocyte derived extracellular vesicles in patients with coronary artery disease differs depending on the presence of certain cardiovascular risk fac
Presentation
The expression of pro-coagulatory endothelial- and monocyte derived extracellular vesicles in patients with coronary artery disease differs depending on the presence of certain cardiovascular risk fac
Peak creatine kinase and cardiac troponin I levels and dual time point myocardial SPECT CT
Presentation
Peak creatine kinase and cardiac troponin I levels and dual time point myocardial SPECT CT
Increased frailty due to myocardial infarction is an independent predictor of long-term survival in patients with acute myocardial infarction
Presentation
Increased frailty due to myocardial infarction is an independent predictor of long-term survival in patients with acute myocardial infarction
New frailty assessment based on routine nurse anamnesis before discharge is a strong predictor of all-cause mortality in patients with myocardial infarction
Presentation
New frailty assessment based on routine nurse anamnesis before discharge is a strong predictor of all-cause mortality in patients with myocardial infarction

ESC 365 is supported by